Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

washingtonexaminer.com - David Marin - Big Pharma's patent monopoly is stealing your paycheck - and driving up costs
Big Pharma's patent monopoly is stealing your paycheck - and driving up costs
Washington Examiner

A tsunami of healthcare costs is crashing into the budgets of U.S. businesses. Each new wave forces employers to devote more resources to healthcare and fewer to employee wages, benefits, and investments for growth. Beyond the workplace, families…

fool.com - Sarah Sidlow - IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
The Motley Fool

The iShares Global Healthcare ETF (IXJ -0.13%) offers broad sector diversification and lower volatility, while the State Street SPDR S&P Pharmaceuticals ETF (XPH -0.73%) provides concentrated exposure to U.S. drugmakers. Investors seeking…

marketbeat.com - NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Rating of 'Moderate Buy' by Brokerages
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Rating of 'Moderate Buy' by Brokerages
MarketBeat

Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) have received an average rating of 'Moderate Buy' from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. One research analyst has…

marketbeat.com - Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to Strong-Buy
Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to Strong-Buy
MarketBeat

Royalty Pharma (NASDAQ:RPRX - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a 'buy' rating to a 'strong-buy' rating in a research note issued to investors on Saturday, Wall Street Zen reports. How Royalty…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Rating Increased to Hold at Wall Street Zen
Avalyn Pharma (NASDAQ:AVLN) Rating Increased to Hold at Wall Street Zen
MarketBeat

Avalyn Pharma (NASDAQ:AVLN - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports. AVLN has…

marketbeat.com - California State Teachers Retirement System Increases Holdings in Royalty Pharma PLC $RPRX
California State Teachers Retirement System Increases Holdings in Royalty Pharma PLC $RPRX
MarketBeat

California State Teachers Retirement System lifted its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5,065.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission…

swissinfo.ch - swissinfo.ch - Dutch ambassador visits survivors of fatal Swiss coach accident
Dutch ambassador visits survivors of fatal Swiss coach accident
www.swissinfo.ch

Switzerland juggles fighting crime against threat to tech-privacy industry Read more: Switzerland juggles fighting crime against threat to tech-privacy industry US-Canada trade war escalates, 9/11 25 years on, and a medical first involving a pig…

seekingalpha.com - High Alpha Professor - AutoZone: The Business Held Up, The Valuation Did Not (NYSE:AZO)
AutoZone: The Business Held Up, The Valuation Did Not (NYSE:AZO)
Seeking Alpha

AutoZone remains a Buy, now driven by compressed valuation and moderate earnings growth rather than expectations of rapid margin normalization. Revenue growth exceeded expectations, with commercial sales up 10% and the store base surpassing 8,000…

theguardian.com - Rory Carroll - Donald Trump says he would 'love' to see united Ireland
Donald Trump says he would 'love' to see united Ireland
The Guardian

Donald Trump has said he would “love” to see a united Ireland and that it “may as well happen now”. The US president appeared to endorse the push for constitutional change on the island at the start of a two-day visit to…

thehindubusinessline.com - Movers & Shakers: Stocks that will see action this week
Movers & Shakers: Stocks that will see action this week
BusinessLine

Allied Blenders and Distillers (₹631.85) The stock of Allied Blenders and Distillers has been charting a sideways trend since mid-July, where it has been oscillating between ₹585 and ₹650. Nevertheless, the broader trend…

thehill.com - Nathaniel Weixel - CDC declares cyclospora outbreak over
CDC declares cyclospora outbreak over
The Hill

After nearly 13,000 cases and more than 500 hospitalizations, the Centers for Disease Control and Prevention (CDC) said there is no longer any risk of contracting cyclosporiasis from the source linked to the outbreak. David Paul Morris/Bloomberg…

thehindubusinessline.com - Acutaas Chemicals: Offering multi-vertical growth runway
Acutaas Chemicals: Offering multi-vertical growth runway
BusinessLine

Acutaas Chemicals has delivered close to 6x returns since its IPO in 2021, supported by a 31 per cent revenue CAGR and 45 per cent EPS CAGR over FY21-26. On the product front, the company has expanded beyond its core advanced pharma intermediates…

indianexpress.com - Manraj Grewal Sharma - Punjab talks drugs again. Its children are still paying the price
Punjab talks drugs again. Its children are still paying the price
The Indian Express

This week, that future claimed another victim. Gulzar Singh, a labourer from Sangrur, consumed Celphos tablets after allegedly being threatened by the local sarpanch and others for questioning a sitting minister about rampant drug abuse in the…

cyclingnews.com - Dani Ostanek - Vuelta a España: Enric Mas passes arduous final mountain test to keep red as Mikel Landa soars to stage 20 breakaway victory atop Collado del Alguacil
Vuelta a España: Enric Mas passes arduous final mountain test to keep red as Mikel Landa soars to stage 20 breakaway victory atop Collado del Alguacil
Cyclingnews

Enric Mas (Movistar) put the finishing touches on a certain Vuelta a España victory atop the steep slopes of the Collado de Alguacil, the Spaniard surviving a day of long-range GC action to hold onto the red jersey after five hours of…

thehindubusinessline.com - Jubilant Pharmova's Spokane facility gets VAI classification from US FDA
Jubilant Pharmova's Spokane facility gets VAI classification from US FDA
BusinessLine

Jubilant Pharmova Ltd on Friday said the US health regulator has classified the contract manufacturing (CMO) facility of its step-down subsidiary, Jubilant HollisterStier LLC, in Spokane, Washington, as 'Voluntary Action Indicated' (VAI). The US…

Receive a Daily briefing on Pharma Industry News

Get Started